|Articles|October 1, 1995

October 1995
Volume 1
Issue 2

Concentration of Healthcare Costs in Asthma

Author(s)James T. Li, MD, PhD, George Xakellis, MD, MBA, Eric S. Edell, MD

Download PDF: Concentration of Healthcare Costs in Asthma

Articles in this issue

over 30 years ago

Article

The Safety and Efficacy of Continuous Heparin Infusion Therapy in the Home

over 30 years ago

Article

The Virginia Health Outcomes Project: A Unique Approach to Lowering Medicaid Costs and Improving Health Outcomes

over 30 years ago

Article

Education of Patients and Family: A JCAHO Requirement -- One Medical Center's Approach

over 30 years ago

Article

Partial Medication Compliance: The Enigma in Poor Medical Outcomes

over 30 years ago

Article

The Integration of Case Management and Pharmacy in Managed Care Environments

over 30 years ago

Article

Prevention and Treatment of Osteoporosis

over 30 years ago

Article

Physician Financial Incentives in Managed Care: Their Impact on Healthcare for the Elderly

over 30 years ago

Article

Comparing Quality in Managed Care and Fee-for-Service Delivery Systems

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

Orthopedic surgeon holds bone x-ray | Image Credit: © tippapatt - stock.adobe.com

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

ByHannah I. Travers, MD,Mikhail Kuznetsov, MD,John Mazzocco, MD,Nicholas Pagani, MD,Tricia Ide, DNP, RN,Brian L. Hollenbeck, MD,Eric L. Smith, MD

June 3rd 2026

Concentration of Healthcare Costs in Asthma

Articles in this issue

Related Content

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

Trending on AJMC

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD

AI Reshaping Diabetes Care From Nutrition to Clinical Decisions

Contributor: How to Pair Data With Clinical Care to Manage Health Care Costs

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD